MLL is a frequent target for recurrent translocations in acute leukemia cases, which can be classified as acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), or mixed lineage (biphenotypic) leukemia (MLL). Here, KMT2A is linked to acute lymphoblastic leukemia.